Affordability Gap: Why Tier-2 Cities Are Critical for MedTech Growth

The healthcare industry in India is valued at nearly USD 372 billion in 2025 and is expected to cross USD 500 billion by 2030, growing across diagnostics, devices, and hospital infrastructure.
Within this ecosystem, the medical device market in India - about USD 12 billion today - is projected to touch USD 50 billion by 2030, at an almost 20 percent CAGR.

Yet, this growth hides a structural imbalance. Nearly 70–80 percent of India’s medical devices are imported, keeping prices high and adoption low.
In FY 24 alone, India imported USD 8.2 billion worth of medical devices, much of it high-end diagnostic and surgical equipment priced for Western healthcare economics.

The ₹20,000-Crore Latent Demand

Tier-2 and Tier-3 cities represent almost ₹20,000 crore of unrealised MedTech demand, driven by hospital expansion, diagnostic chain growth, and state-level procurement.
However, high capital costs, thin hospital margins, and limited financing have locked this opportunity out of reach.

The market exists - the affordability doesn’t.

Why the Affordability Gap Persists

1. Import Dependence:
With 80 percent import reliance, device prices are inflated by tariffs, forex risk, and distributor margins.

2. Capital-Heavy Procurement:
Most Tier-2 hospitals operate on tight cash cycles and cannot justify long-breakeven CAPEX for equipment like MRI, cath-labs, or robotic systems.

3. Skewed R&D Priorities:
Many global devices are over-engineered for Indian operating conditions, where maintenance support, power stability, and trained technicians are inconsistent.

4. Financing Void:
Few leasing or pay-per-use models exist for smaller hospitals. Traditional loans treat equipment as depreciating assets, not productivity multipliers.

Tier-2 India: The Untapped Growth Zone

Contrary to perception, Tier-2 cities are not low-value markets; they are high-volume healthcare hubs.
Cities like Indore, Coimbatore, Lucknow, Bhubaneswar, and Vizag have become regional referral centres, drawing patients from 200–300 km catchment areas.

Why Tier-2 markets matter:

• Rising middle-income population and insurance coverage.

• Lower real-estate and staffing costs for hospitals.

• Strong patient trust in local specialists.

• Government incentives for regional medical hubs and MedTech parks.

These cities are where the next decade of healthcare sector growth in India will play out.

Frugal Innovation: Designing for Bharat

India’s MedTech opportunity depends on local design for local economics.
Instead of repurposing Western models, innovators must build rugged, repairable, and resource-light devices - engineered for reliability over perfection.

Scalable examples include:

• Portable diagnostics: battery-operated ECG, X-ray, and lab devices for low-power settings.

• Cloud-linked imaging: AI-assisted teleradiology that connects Tier-2 hospitals to metro specialists.

• Modular equipment: scalable systems that can start small and expand with demand.

• Subscription-based devices: reducing upfront CAPEX through OPEX models.

This is not about cheap innovation - it’s about cost-intelligent innovation that delivers 80 percent of functionality at 50 percent of cost.

Digital Infrastructure as the Equaliser

The Ayushman Bharat Digital Mission (ABDM) is quietly transforming affordability.
By standardising health records and enabling interoperability, it reduces technology fragmentation and improves ROI for connected devices.

Tier-2 hospitals adopting digital diagnostics, tele-ICU, or AI-based triage systems are already seeing measurable impact:

• 25–30 percent shorter turnaround time in pathology and radiology.

• 15–20 percent reduction in re-tests due to error tracking.

• Better resource utilisation through cloud-based scheduling and data sharing.

Digital readiness has become a new determinant of affordability - because it maximises every rupee of investment.

Policy Tailwinds Strengthening Local Value Chains

India’s policy ecosystem is finally aligned with Tier-2 growth.

Key enablers include:

• PLI Scheme (₹3,420 crore): supporting 270 + domestic MedTech products.

• PRIP Programme (₹5,000 crore): driving R&D and innovation pipelines.

• Medical Device Parks (₹100 crore each): improving local component manufacturing.

• Public procurement reforms: prioritising domestic bidders and multi-vendor contracts.

Together, these initiatives aim to reduce device cost by 20–30 percent through localisation and value-chain integration.

Financing Models that Make Technology Work

Traditional equipment loans don’t fit smaller hospitals.
Emerging models - Device-as-a-Service (DaaS), leasing partnerships, and revenue-share deployments - are now proving commercially viable.

These models:

• Convert CAPEX into manageable monthly OPEX.

• Tie payments to utilisation metrics.

• Encourage preventive maintenance via vendor accountability.

By aligning economics with outcomes, they bridge the affordability divide while ensuring sustainability for both hospitals and OEMs.

The Road Ahead: Local Build, Digital Scale

To unlock the Tier-2 opportunity, India’s MedTech ecosystem must align around four imperatives:

1. Local manufacturing and component ecosystems.

2. Outcome-linked financing models.

3. Digital integration through ABDM-ready platforms.

4. Clinician-led validation and training.

If executed cohesively, these could double MedTech adoption outside metros within five years - while reducing total device cost by a third.

Conclusion: Building for Bharat, Not Just India

India’s MedTech future depends on affordability - and affordability depends on Tier-2 India.
These cities hold the balance between aspiration and accessibility, where the next wave of hospital growth and patient care transformation will emerge.

For innovators and investors, the lesson is clear: growth will come not from pushing premium devices, but from re-engineering economics - designing for scale, sustainability, and inclusivity.

At GrowthJockey, this is the principle behind our venture architecture - helping healthcare innovators close the affordability gap through data-driven design, digital enablement, and outcome-based business models.
Because when MedTech becomes accessible to Bharat, it doesn’t just grow markets - it builds a healthier nation.

FAQs

1. Why are Tier-2 cities vital for MedTech growth?
They account for most hospital expansions and represent ₹20,000 crore of unmet MedTech demand.

2. What limits adoption in smaller cities?
High device prices, import dependence, limited finance options, and maintenance challenges.

3. How can companies make devices affordable?
Through local production, modular design, and flexible OPEX pricing.

4. How does digital healthcare reduce costs?
By improving efficiency, reducing re-tests, and enabling remote diagnostics via ABDM.

5. What government initiatives support localisation?
PLI, PRIP, and MedTech Park schemes that encourage domestic manufacturing and innovation.